Close Menu

Trovagene

NEW YORK (GenomeWeb News) – PerkinElmer this week said that its board of directors has declared a quarterly dividend of $.07 per share payable on Aug. 10, to all shareholders of record at the close of business on July 20.

NEW YORK (GenomeWeb News) – Trovagene today announced that underwriters of its public offering have exercised the over-allotment option to purchase 172,500 additional units to raise a total of nearly $10.6 million in gross proceeds.

Trovagene said this week that it has entered into a memorandum of understanding with Strand Life Sciences to offer Trovagene's urine-based human papillomavirus screening test in India and South Asia.

NEW YORK (GenomeWeb News) – Trovagene today said that it has entered into a memorandum of understanding with Strand Life Sciences, under which Strand will license and validate Trovagene's human papillomavirus urine test and high-risk HPV DNA assay.

This article has been updated from a previous version to correct the list price of the QX100 system.

NEW YORK (GenomeWeb News) – Trovagene announced late on Tuesday the pricing of a public offering of 1.15 million units and said that its shares will begin trading on the Nasdaq Capital Market today under ticker symbol "TROV".

This article has been updated from a previous version to include information about the current status of Fluidigm's collaboration with Novartis.

Trovagene said this week that Carlo Croce has joined its scientific advisory board.

Originally published May 2. Updated May 3 to include additional details of Trovagene's product commercialization plans.

Molecular diagnostic company Trovagene has appointed Charlie Rodi to vice president and chief technology officer.

Pages

According to Gizmodo, researchers have developed a list of a million nucleic acid-like polymers that could store genetic information.

An opinion piece in the Washington Post argues that golden rice could save the sight and lives of many children.

US National Institutes of Health has issued a new draft data-sharing policy, ScienceInsider reports.

In Cell this week: analysis of immune microenvironment in hepatocellular carcinoma, proteogenomic analysis of clear cell renal cell carcinoma, and more.